Yelin Lapidot Holdings Management Ltd. Sells 12,644 Shares of Perrigo Company plc (NYSE:PRGO)

Yelin Lapidot Holdings Management Ltd. lowered its stake in shares of Perrigo Company plc (NYSE:PRGOFree Report) by 4.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 267,915 shares of the company’s stock after selling 12,644 shares during the period. Perrigo accounts for 1.2% of Yelin Lapidot Holdings Management Ltd.’s investment portfolio, making the stock its 23rd biggest holding. Yelin Lapidot Holdings Management Ltd.’s holdings in Perrigo were worth $6,888,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Pacer Advisors Inc. boosted its position in Perrigo by 2.1% during the fourth quarter. Pacer Advisors Inc. now owns 20,337 shares of the company’s stock valued at $523,000 after buying an additional 427 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Perrigo by 2.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 21,617 shares of the company’s stock valued at $567,000 after purchasing an additional 436 shares during the period. Voisard Asset Management Group Inc. lifted its position in Perrigo by 9.7% during the third quarter. Voisard Asset Management Group Inc. now owns 5,100 shares of the company’s stock valued at $134,000 after buying an additional 450 shares during the period. Central Pacific Bank Trust Division grew its position in shares of Perrigo by 33.3% in the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock worth $51,000 after buying an additional 500 shares during the period. Finally, Amalgamated Bank boosted its stake in Perrigo by 0.8% during the fourth quarter. Amalgamated Bank now owns 64,086 shares of the company’s stock worth $1,648,000 after acquiring an additional 522 shares in the last quarter. 95.91% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently issued reports on PRGO. Piper Sandler lowered shares of Perrigo from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $34.00 to $27.00 in a report on Monday, January 6th. StockNews.com downgraded Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Finally, Argus downgraded Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday, January 14th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $35.00.

View Our Latest Stock Analysis on Perrigo

Insider Activity at Perrigo

In other news, Director Jeffrey B. Kindler sold 17,598 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $28.27, for a total value of $497,495.46. Following the transaction, the director now owns 5,409 shares of the company’s stock, valued at $152,912.43. This trade represents a 76.49 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.40% of the stock is currently owned by company insiders.

Perrigo Price Performance

Shares of PRGO opened at $24.09 on Friday. The firm has a fifty day simple moving average of $24.87 and a two-hundred day simple moving average of $26.18. The firm has a market cap of $3.29 billion, a PE ratio of -20.59 and a beta of 0.54. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. Perrigo Company plc has a 1-year low of $23.14 and a 1-year high of $33.46.

Perrigo (NYSE:PRGOGet Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.93 EPS for the quarter, beating analysts’ consensus estimates of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. On average, equities analysts anticipate that Perrigo Company plc will post 2.56 EPS for the current year.

Perrigo Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Friday, March 7th will be issued a $0.29 dividend. This is an increase from Perrigo’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.82%. Perrigo’s dividend payout ratio (DPR) is presently -99.15%.

About Perrigo

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Featured Stories

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGOFree Report).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.